Novartis (NOVN.S) is to cut up to 680 jobs in its development organisation, which helps bring its drugs to market, the Swiss pharmaceuticals company said on Tuesday.
Around 440 jobs will go in Switzerland and up to 240 in the United States over the next two to three years, the Basel-based company said.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,